Development and description of GETT: a Genetic testing Evidence Tracking Tool
-
François Rousseau
Abstract
Background: The completion of the Human Genome Project has increased the pace of discovery of genetic markers for disease. Despite tremendous efforts in fundamental research, clinical applications still lag behind expectations, partly due to the lack of effective tools to systematically search for and summarize published data relative to the clinical assessment of new diagnostic molecular tests.
Methods: Through a collaborative process using published tools and an expert panel, we developed a detailed checklist of the evidence that needs to be collected or produced to evaluate the potential usefulness of a new molecular diagnostic test. This tool is called GETT, for Genetic testing Evidence Tracking Tool.
Results: GETT allows 1) researchers to summarize the current evidence and to identify knowledge gaps for further research and; 2) stakeholders to collect data related to a given molecular test and improve their decision-making process. GETT comprises 72 clearly defined items/questions, grouped into 10 categories and 26 sub-themes, including an overview of disease epidemiology and genetics, the available diagnostic tools, and their analytical and clinical performances, availability of quality control programs, laboratory and clinical best practice guidelines, clinical utility, and impact on health care and psycho-social, ethical and legal implications. It also includes a summary of the evidence available and attempts to prioritise knowledge gaps related to the testing. We also compare GETT to other existing frameworks.
Conclusions: This systematic evidence-based tracking tool, which is more detailed than existing frameworks and provides clear definition for each item, will help streamline collection of the available evidence to appraise the potential for clinical application of new molecular diagnostic tests and prioritize research to produce the evidence-base relative to the clinical implementation of molecular diagnostic tests.
Clin Chem Lab Med 2010;48:1397–407.
©2010 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorial
- Darwinian evolution or regression? The fate of laboratory professionals
- Review
- Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis
- Minireview
- Laboratory diagnostics in acute poisoning: critical overview
- Opinion Papers
- On the origins of physicians: Darwinian or Lamarckian evolution?
- Observed, unknown distributions of clinical chemical quantities should be considered to be log-normal: a proposal
- Guidelines and Recommendations
- Development and description of GETT: a Genetic testing Evidence Tracking Tool
- Genetics and Molecular Diagnostics
- DNA sequencing errors in molecular diagnostics of filamin myopathy
- High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene
- General Clinical Chemistry and Laboratory Medicine
- Detection of serum free light chains: the problem with antigen excess
- Hepcidin concentrations and iron homeostasis in preeclampsia
- Automated assay for non-transferrin-bound iron in serum samples
- A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose
- Evaluation of a multiplex assay for adipokine concentrations in obese children
- The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
- Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265
- The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects
- Cancer Diagnostics
- Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers
- VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma
- Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer
- Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients
- Spurious increase in serum chromogranin A: the role of heterophilic antibodies
- Infectious Diseases
- Identification and evaluation of a new nucleic acid amplification test target for specific detection of Mycobacterium tuberculosis
- Application of an oligonucleotide microarray-based nano-amplification technique for the detection of fungal pathogens
- Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma
- Evaluation of two sirolimus assays using the ARCHITECT-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method
- Widespread use of point-of-care testing is irreconcilable with the present-day quest for safety
- Congress Abstracts
- 3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry Salzburg, Austria, 27-30 October 2010
Articles in the same Issue
- Editorial
- Darwinian evolution or regression? The fate of laboratory professionals
- Review
- Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis
- Minireview
- Laboratory diagnostics in acute poisoning: critical overview
- Opinion Papers
- On the origins of physicians: Darwinian or Lamarckian evolution?
- Observed, unknown distributions of clinical chemical quantities should be considered to be log-normal: a proposal
- Guidelines and Recommendations
- Development and description of GETT: a Genetic testing Evidence Tracking Tool
- Genetics and Molecular Diagnostics
- DNA sequencing errors in molecular diagnostics of filamin myopathy
- High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene
- General Clinical Chemistry and Laboratory Medicine
- Detection of serum free light chains: the problem with antigen excess
- Hepcidin concentrations and iron homeostasis in preeclampsia
- Automated assay for non-transferrin-bound iron in serum samples
- A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose
- Evaluation of a multiplex assay for adipokine concentrations in obese children
- The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
- Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265
- The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects
- Cancer Diagnostics
- Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers
- VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma
- Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer
- Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients
- Spurious increase in serum chromogranin A: the role of heterophilic antibodies
- Infectious Diseases
- Identification and evaluation of a new nucleic acid amplification test target for specific detection of Mycobacterium tuberculosis
- Application of an oligonucleotide microarray-based nano-amplification technique for the detection of fungal pathogens
- Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma
- Evaluation of two sirolimus assays using the ARCHITECT-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method
- Widespread use of point-of-care testing is irreconcilable with the present-day quest for safety
- Congress Abstracts
- 3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry Salzburg, Austria, 27-30 October 2010
